0001870913-23-000009.txt : 20231017
0001870913-23-000009.hdr.sgml : 20231017
20231017163209
ACCESSION NUMBER: 0001870913-23-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231013
FILED AS OF DATE: 20231017
DATE AS OF CHANGE: 20231017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shanmugam Muthusamy
CENTRAL INDEX KEY: 0001870913
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31812
FILM NUMBER: 231329947
MAIL ADDRESS:
STREET 1: C/O ANI PHARMACEUTICALS, INC.
STREET 2: 210 MAIN STREET WEST
CITY: BAUDETTE
STATE: MN
ZIP: 56623
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANI PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001023024
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 582301143
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 MAIN STREET WEST
CITY: BAUDETTE
STATE: MN
ZIP: 56623
BUSINESS PHONE: 2186343500
MAIL ADDRESS:
STREET 1: 210 MAIN STREET WEST
CITY: BAUDETTE
STATE: MN
ZIP: 56623
FORMER COMPANY:
FORMER CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19991228
FORMER COMPANY:
FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC
DATE OF NAME CHANGE: 19991027
4
1
wk-form4_1697574720.xml
FORM 4
X0508
4
2023-10-13
0
0001023024
ANI PHARMACEUTICALS INC
ANIP
0001870913
Shanmugam Muthusamy
C/O ANI PHARMACEUTICALS, INC.
210 MAIN STREET WEST
BAUDETTE
MN
56623
1
1
0
0
HEAD OF R&D, COO-NOVITIUM OPS
1
Common Stock
47407
D
Common Stock
2023-10-13
4
S
0
11937
57.58
D
1070683
I
Held by Esjay LLC
Common Stock
2023-10-16
4
S
0
13063
58.31
D
1057620
I
Held by Esjay LLC
Common Stock
5000
I
Held by SS Pharma LLC
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $57.36 to $58.00, inclusive.
The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $57.75 to $58.88, inclusive.
The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.
/s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook
2023-10-17